Thyroid dysfunction associated with immunotherapy for patients with cancer
Open Access
- 1 December 1991
- Vol. 68 (11) , 2384-2390
- https://doi.org/10.1002/1097-0142(19911201)68:11<2384::aid-cncr2820681109>3.0.co;2-a
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*Journal of Clinical Endocrinology & Metabolism, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- INDUCTION OF HYPERTHYROIDISM BY INTERFERON-α-2bThe Lancet, 1989
- Hypothyroidism after interleukin-2 therapy.Journal of Clinical Oncology, 1989
- HYPOTHYROIDISM AND GOITRE DURING INTERLEUKIN-2 THERAPY WITHOUT LAK CELLSThe Lancet, 1989
- Clinical Utility and Cost-Effectiveness of Sensitive Thyrotropin Assays in Ambulatory and Hospitalized PatientsMayo Clinic Proceedings, 1988
- An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986